ORAL MUCOSA EROSION side effect
What is ORAL MUCOSA EROSION ?ORAL MUCOSA EROSION : Rapamune Side Effects Report #5528903-5
Health Professional from NORWAY reported RAPAMUNE problem on Nov 27, 2007. Female patient was diagnosed with liver transplant and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: oral mucosa erosion, pyrexia, rash, . RAPAMUNE dosage: unknown. During the same period patient was treated with BUMETANIDE, NOVORAPID, POTASSIUM CHLORIDE, PREDNISOLONE, ALBYL, CALCIGRAN, CELLCEPT, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
ORAL MUCOSA EROSION : Avelox Side Effects Report #5566375-5
AVELOX problem was reported by a Physician from JAPAN on Dec 05, 2007. Male patient, 54 years of age, was diagnosed with nasopharyngitis and was treated with AVELOX. After drug was administered, patient experienced the following problems/side effects: diarrhoea, oral mucosa erosion, . AVELOX dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. During the same period patient was treated with MUCOSTA, LOXONIN. Patient was hospitalized. Patient recovered.
ORAL MUCOSA EROSION : Cipro Side Effects Report #5649920-0
Consumer or non-health professional from GERMANY reported CIPRO problem on Feb 28, 2008. Female patient, 88 years of age, was diagnosed with cystitis, oedema, coronary artery disease, pain, pneumonia and was treated with CIPRO. After drug was administered, patient experienced the following problems/side effects: blister, lip erosion, oral mucosa erosion, pruritus, pyrexia, rash, stevens-johnson syndrome, toxic epidermal necrolysis, . CIPRO dosage: UNIT DOSE: 250 MG. During the same period patient was treated with FUROSEMID, CORVATON RETARD, NOVALGIN, CEFTRIAXONE, KLACID. Patient died.
ORAL MUCOSA EROSION : Avelox Side Effects Report #5624498-6
AVELOX problem was reported by a Physician from JAPAN on Feb 04, 2008. Male patient, 60 years of age, weighting 145.5 lb, was diagnosed with sinusitis and was treated with AVELOX. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, lip erosion, oral mucosa erosion, pharyngeal inflammation, pyrexia, stevens-johnson syndrome, vulvar erosion, . AVELOX dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. During the same period patient was treated with RULID. Patient was hospitalized. Patient recovered.
ORAL MUCOSA EROSION : Avelox Side Effects Report #5627309-8
Physician from JAPAN reported AVELOX problem on Feb 08, 2008. Male patient, 60 years of age, weighting 145.5 lb, was diagnosed with sinusitis and was treated with AVELOX. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, lip erosion, oral mucosa erosion, pharyngeal inflammation, pyrexia, stevens-johnson syndrome, vulvar erosion, . AVELOX dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 400 MG. During the same period patient was treated with RULID, GENINAX. Patient was hospitalized. Patient recovered.
ORAL MUCOSA EROSION : Cipro Side Effects Report #5645170-2
CIPRO problem was reported by a Consumer or non-health professional from GERMANY on Feb 18, 2008. Female patient, 67 years of age, was diagnosed with sepsis, hypertensive crisis, hypertension and was treated with CIPRO. After drug was administered, patient experienced the following problems/side effects: blister, nikolsky's sign, oral mucosa erosion, pain of skin, pyrexia, rash macular, toxic epidermal necrolysis, . CIPRO dosage: unknown. During the same period patient was treated with BAYOTENSIN, LORZAAR PLUS, LORZAAR PLUS, NITROLINGUAL. Patient died.
ORAL MUCOSA EROSION : Sorafenib Side Effects Report #5607862-0
Health Professional from FRANCE reported SORAFENIB problem on Nov 29, 2007. Male patient, 59 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: asthenia, erythema multiforme, oral mucosa erosion, pyrexia, rash, . SORAFENIB dosage: unknown. During the same period patient was treated with SUNITINIB, BEVACIZUMAB. Patient recovered.